Klinische studies dienst urologie

Bekijk het overzicht van de studies die op dit moment aangeboden kunnen worden aan patiënten met urologische tumoren en andere urologische problemen.

Blaas- en urinewegentumoren


Phase II prospective trial to evaluate the impact of 18FFDG-PET-CT in stratifying patients with primary muscle invasive bladder cancer and adapting the treatment accordingly.


Er zijn momenteel geen studies beschikbaar.



Glycosaminoglycan scores for surveillance of recurrence in Leibovich points ≥ 5 non-metastatic clear cell RCC

Overactieve blaas

CARE Studie

Continence Achieved through Recording of Electrophysiology (CARE) Study: A Prospective Study to Evaluate the Safety and Feasibility of using the Closed Loop Medical Sacral Nerve Stimulation System (the Repose™ System) in the treatment of Symptoms of Overactive Bladder

  • Inclusie criteria: oa >= 18 jaar, Chronische OAB (> 12 maanden), Urgentie incontinentie, Onder stabiele OAB medicatie, Restblaasvolume <150cc, Geschikte kandidaat om een SNS-procedure te ondergaan
  • Exclusie criteria: oa Hoofddiagnose stressincontinentie, Neurogene blaas, Interstitiële cystitis, Urinewegobstructie of urethrastrictuur, Botox injecties voor OAB (<9 maanden geleden)
  • Local site Principal Investigator: prof. dr. Frank Van der Aa
  • Sub-investigator: dr. Lucas Landen
  • More information: ACTRN12622000999730



Magnetic detection of sentinel lymph nodes in patients with penile cancer from Belgium

  • Inclusion criteria: Penile cancer, suspected squamous cell carcinoma, ≥ pT1b G2 N0 M0, surgical intervention with a dynamic sentinel node biopsy procedure (using standard intradermal nanocolloid) being part of the surgical plan
  • Local site Principal Investigator (Urology): prof. dr. Maarten Albersen
  • Sub-investigator (Nuclear Medicine): prof. dr. Karolien Goffin
  • More information: dr. Laura Elst (Phd): 016 34 73 58.



Cytoreductive prostatectomy versus standard of care as a Local treatment option for primary Metastatic Prostate cancer: a phase II feasibility trial (LoMP II)

  • Inclusion criteria: Local treatment option for primary metastatic hormone sensitive prostate cancer
  • Study Principal Investigator: prof. dr. Piet Ost (UZ Gent)
  • Local site Principal Investigator: prof. dr. Wouter Everaerts
  • More information: NCT03655886


High precision imaging of prostate specific membrane antigen for personalized treatment in prostate cancer


Er zijn momenteel geen studies beschikbaar.

Urinaire incontinentie


Diagnostic tool and therapeutic strategy for acute cold-induced urgency (ACIU) part 2: optimizing the protocol

  • Inclusion criteria: All patients with an overactive bladder for which a Urodynamic investigation is scheduled. Note that patients with prior pelvic floor surgery, neurological disorder or peripheral neuropathy are excluded from the study.
  • Local site Principal Investigator: prof. dr. Wouter Everaerts
  • Sub-investigator: prof. dr. Frank Van der Aa
  • More information: dr. Lucas Landen

Urinaire retentie

Er zijn momenteel geen studies beschikbaar.



Multicentric study on Infections of the Urinary tract after Stent removal

  • Inclusion criteria: Patients, 18 years of age and older who receive a ureteral stent during any endoscopic procedure will be approached to participate in the study
  • Local site Principal Investigator: dr. Carl Van Haute
  • Sub-investigator (Urology): prof. dr. Ben Van Cleynenbreugel
  • More information: NCT05329883
Laatste aanpassing: 7 maart 2024